Literature DB >> 20941594

Desensitization of δ-opioid receptors in nucleus accumbens during nicotine withdrawal.

Michael J McCarthy1, Hailing Zhang, Norton H Neff, Maria Hadjiconstantinou.   

Abstract

RATIONALE: The synthesis and release of met-enkephalin and β-endorphin, endogenous ligands for δ-opioid peptide receptors (DOPrs), are altered following nicotine administration and may play a role in nicotine addiction.
OBJECTIVES: To investigate the consequences of altered opioidergic activity on DOPr expression, coupling, and function in striatum during early nicotine withdrawal.
METHODS: Mice received nicotine-free base, 2 mg/kg, or saline, subcutaneously (s.c.), four times daily for 14 days and experiments performed at 24, 48, and 72 h after drug discontinuation. DOPr binding and mRNA were evaluated by [³H]naltrindole autoradiography and in situ hybridization. DOPr coupling and function were investigated by agonist pCl-DPDPE-stimulated [³⁵S]GTPγS binding autoradiography and inhibition of adenylyl cyclase activity.
RESULTS: During nicotine withdrawal DOPr binding was unaltered in caudate/putamen (CPu) and nucleus accumbens (NAc) shell and core. Receptor mRNA was slightly increased in the shell at 72 h, but significant elevations were observed in prefrontal cortex and hippocampus. pCl-DPDPE-stimulated [³⁵S]GTPγS binding was attenuated in NAc, but not CPu. In the shell, binding was decreased by 48 h and remained decreased over 72 h; while in the core, significant reduction was seen at 72 h. Basal adenylyl cyclase activity was suppressed in striatum at 24 h, but recovered by 48 h. DOPr stimulation with pCl-DPDPE failed to inhibit adenylyl cyclase activity at 24 h and produced attenuated responses at 48 and 72 h.
CONCLUSIONS: These observations suggest that DOPr coupling and function are impaired in the NAc during nicotine withdrawal. DOPr desensitization might be involved in the affective component of nicotine withdrawal.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20941594     DOI: 10.1007/s00213-010-2028-z

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  78 in total

1.  CREB activity in the nucleus accumbens shell controls gating of behavioral responses to emotional stimuli.

Authors:  Michel Barrot; Jocelien D A Olivier; Linda I Perrotti; Ralph J DiLeone; Olivier Berton; Amelia J Eisch; Soren Impey; Daniel R Storm; Rachael L Neve; Jerry C Yin; Venetia Zachariou; Eric J Nestler
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-06       Impact factor: 11.205

2.  Selective reward deficit in mice lacking beta-endorphin and enkephalin.

Authors:  Michael D Hayward; John E Pintar; Malcolm J Low
Journal:  J Neurosci       Date:  2002-09-15       Impact factor: 6.167

3.  Reward and somatic changes during precipitated nicotine withdrawal in rats: centrally and peripherally mediated effects.

Authors:  S S Watkins; L Stinus; G F Koob; A Markou
Journal:  J Pharmacol Exp Ther       Date:  2000-03       Impact factor: 4.030

4.  Dramatic decreases in brain reward function during nicotine withdrawal.

Authors:  M P Epping-Jordan; S S Watkins; G F Koob; A Markou
Journal:  Nature       Date:  1998-05-07       Impact factor: 49.962

5.  Effects of nicotine on beta-endorphin, alpha MSH, and ACTH secretion by isolated perfused mouse brains and pituitary glands, in vitro.

Authors:  M A Marty; V G Erwin; K Cornell; J M Zgombick
Journal:  Pharmacol Biochem Behav       Date:  1985-02       Impact factor: 3.533

6.  Alteration of intravenous nicotine self-administration by opioid receptor agonist and antagonists in rats.

Authors:  Naila Ismayilova; Mohammed Shoaib
Journal:  Psychopharmacology (Berl)       Date:  2010-04-17       Impact factor: 4.530

7.  Mood and physiological effects of subcutaneous nicotine in smokers and never-smokers.

Authors:  J Foulds; J A Stapleton; N Bell; J Swettenham; M J Jarvis; M A Russell
Journal:  Drug Alcohol Depend       Date:  1997-03-14       Impact factor: 4.492

8.  Nicotine-induced alterations in brain regional concentrations of native and cryptic Met- and Leu-enkephalin.

Authors:  K Pierzchala; A A Houdi; G R Van Loon
Journal:  Peptides       Date:  1987 Nov-Dec       Impact factor: 3.750

9.  Rodent model of nicotine abstinence syndrome.

Authors:  D H Malin; J R Lake; P Newlin-Maultsby; L K Roberts; J G Lanier; V A Carter; J S Cunningham; O B Wilson
Journal:  Pharmacol Biochem Behav       Date:  1992-11       Impact factor: 3.533

10.  In vitro autoradiography of receptor-activated G proteins in rat brain by agonist-stimulated guanylyl 5'-[gamma-[35S]thio]-triphosphate binding.

Authors:  L J Sim; D E Selley; S R Childers
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-01       Impact factor: 11.205

View more
  10 in total

1.  Influence of δ-opioid receptors in the behavioral effects of nicotine.

Authors:  Fernando Berrendero; Ainhoa Plaza-Zabala; Lola Galeote; África Flores; S Andreea Bura; Brigitte L Kieffer; Rafael Maldonado
Journal:  Neuropsychopharmacology       Date:  2012-06-06       Impact factor: 7.853

2.  μ- and δ-opioid-related processes in the accumbens core and shell differentially mediate the influence of reward-guided and stimulus-guided decisions on choice.

Authors:  Vincent Laurent; Beatrice Leung; Nigel Maidment; Bernard W Balleine
Journal:  J Neurosci       Date:  2012-02-01       Impact factor: 6.167

Review 3.  The opioid receptors as targets for drug abuse medication.

Authors:  Florence Noble; Magalie Lenoir; Nicolas Marie
Journal:  Br J Pharmacol       Date:  2015-06-26       Impact factor: 8.739

4.  Operant self-administration of alcohol and nicotine in a preclinical model of co-abuse.

Authors:  A D Lê; Douglas Funk; Steven Lo; Kathleen Coen
Journal:  Psychopharmacology (Berl)       Date:  2014-04-03       Impact factor: 4.530

Review 5.  Molecular Pharmacology of δ-Opioid Receptors.

Authors:  Louis Gendron; Catherine M Cahill; Mark von Zastrow; Peter W Schiller; Graciela Pineyro
Journal:  Pharmacol Rev       Date:  2016-07       Impact factor: 25.468

6.  α4β2 Nicotinic receptors play a role in the nAChR-mediated decline in L-dopa-induced dyskinesias in parkinsonian rats.

Authors:  Maryka Quik; Carla Campos; Tanuja Bordia; Jon-Paul Strachan; Jenny Zhang; J Michael McIntosh; Sharon Letchworth; Kristen Jordan
Journal:  Neuropharmacology       Date:  2013-04-12       Impact factor: 5.250

Review 7.  Endogenous opioid system: a promising target for future smoking cessation medications.

Authors:  Haval Norman; Manoranjan S D'Souza
Journal:  Psychopharmacology (Berl)       Date:  2017-03-11       Impact factor: 4.530

Review 8.  Role for the nicotinic cholinergic system in movement disorders; therapeutic implications.

Authors:  Maryka Quik; Danhui Zhang; Xiomara A Perez; Tanuja Bordia
Journal:  Pharmacol Ther       Date:  2014-05-14       Impact factor: 12.310

9.  Neuronal Nicotinic Acetylcholine Receptor Modulators Reduce Sugar Intake.

Authors:  Masroor Shariff; Maryka Quik; Joan Holgate; Michael Morgan; Omkar L Patkar; Vincent Tam; Arnauld Belmer; Selena E Bartlett
Journal:  PLoS One       Date:  2016-03-30       Impact factor: 3.240

10.  Nicotine increases alcohol self-administration in male rats via a μ-opioid mechanism within the mesolimbic pathway.

Authors:  Esi Domi; Li Xu; Marvin Pätz; Anton Nordeman; Gaëlle Augier; Lovisa Holm; Sanne Toivainen; Eric Augier; Anita C Hansson; Markus Heilig
Journal:  Br J Pharmacol       Date:  2020-08-14       Impact factor: 8.739

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.